StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.78−0.11 (-12.27%)

Close on Nov 18, 2026Market cap $43.89MP/E –Yield –

PDS Biotechnology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

PDS Biotechnology's market cap was $57.04M on Nov 11, 2026, against $36.78M a year earlier. Over the last 5 years it ranged from $11.97M to $375.65M, with a median of $111.53M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$57.04M+55.3%
2025Dec 31, 2025$36.72M-38.8%
2024Dec 31, 2024$60.02M-61.1%
2023Dec 29, 2023$154.11M-59.0%
2022Dec 30, 2022$375.65M+63.1%
2021Dec 31, 2021$230.32M+383.5%
2020Dec 31, 2020$47.64M+240.6%
2019Dec 31, 2019$13.99M-30.4%
2018Dec 31, 2018$20.11M-96.5%
2017Dec 29, 2017$578.30M-20.0%
2016Dec 30, 2016$722.88M+1612.5%
2015Dec 31, 2015$42.21M–

More PDS Biotechnology figures

See a number that looks wrong?